Jeffrey W. Card, Ph.D. Associate Director, Toxicology
Dr. Jeffrey Card joined the Pharmaceutical & Healthcare Group at Intertek Scientific & Regulatory Consultancy (formerly Cantox) in 2007. He works closely with clients in the pharmaceutical and biotechnology industries to design and implement nonclinical toxicology programs, address excipient and drug contaminant issues, conduct risk assessments, and prepare regulatory submissions. Dr. Card also serves as a vital resource and manager of projects related to nanotechnology and nanotoxicology.
After receiving his Ph.D. in Pharmacology and Toxicology from Queen's University, Dr. Card spent 4 years as a postdoctoral fellow at the National Institute of Environmental Health Sciences (NIEHS) in Research Triangle Park, NC. He has over 10 years of research experience in academic and government laboratories, has authored over 30 peer-reviewed articles in the fields of toxicology, physiology, carcinogenesis, and nanotechnology and has given presentations at local, national, and international scientific meetings. His academic and research excellence have been recognized in the form of travel, scholarship, and fellowship awards from the Davies Charitable Foundation, the Canadian Institutes of Health Research (CIHR), the Society of Toxicology (SOT), the American Lung Association of North Carolina, and the National Institutes of Health (NIH). Dr. Card is a member of SOT, the Society of Toxicology of Canada, and the American Association for the Advancement of Science (AAAS).
Need help or have a question?